Tiziana Cotechini
Overview
Explore the profile of Tiziana Cotechini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferrario C, Mackey J, Gelmon K, LeVasseur N, Sorensen P, Oo H, et al.
Clin Cancer Res
. 2024 Nov;
31(3):491-502.
PMID: 39576211
Purpose: Preclinical data motivate clinical evaluation of inhibitors of MAPK-interacting kinases 1 and 2 (MNK1/2). We conducted a phase 1b clinical trial to study target engagement and safety of tomivosertib,...
2.
Lodge-Tulloch N, Pare J, Couture C, Bernier E, Cotechini T, Girard S, et al.
Am J Reprod Immunol
. 2024 Aug;
92(2):e13908.
PMID: 39119763
Problem: Preeclampsia (PE) and fetal growth restriction (FGR) are often associated with maternal inflammation and an increased risk of cardiovascular and metabolic disease in the affected mothers. The mechanism responsible...
3.
Nickel J, Cotechini T, Doiron R
Pathogens
. 2024 May;
13(5).
PMID: 38787248
Introduction: A subset of interstitial cystitis/bladder pain syndrome (IC/BPS) patients experience recurrent urinary tract infection (rUTI) associated with symptom flares. Recurrent UTI subjects with associated IC/BPS were enrolled in the...
4.
Doiron R, Cotechini T, Nickel J
J Urol
. 2024 May;
211(6):797-799.
PMID: 38704743
No abstract available.
5.
Atallah A, Grossman A, Nauman R, Pare J, Khan A, Siemens D, et al.
Int J Cancer
. 2024 Mar;
155(2):352-364.
PMID: 38483404
Treatment for higher-risk non-muscle invasive bladder cancer (NMIBC) involves intravesical immunotherapy with Bacillus Calmette Guérin (BCG); however, disease recurrence and progression occur frequently. Systemic immunity is critical for successful cancer...
6.
Cotechini T, Jones O, Hindmarch C
Methods Mol Biol
. 2022 Dec;
2614:1-15.
PMID: 36587115
In situ profiling of the tumor-immune microenvironment (TiME) requires the ability to co-localize and detect multiple proteins simultaneously. Imaging mass cytometry (IMC), using the Hyperion™ imaging system is a novel...
7.
Lodge-Tulloch N, Toews A, Atallah A, Cotechini T, Girard S, Graham C
Cells
. 2022 Dec;
11(23).
PMID: 36497193
Pregnancy complications can have long-term negative effects on the health of the affected mothers and their children. In this review, we highlight the underlying inflammatory etiologies of common pregnancy complications...
8.
Thirumal S, Jamzad A, Cotechini T, Siemens D, Mousavi P
Annu Int Conf IEEE Eng Med Biol Soc
. 2022 Sep;
2022:426-429.
PMID: 36085862
Imaging mass cytometry (IMC) is a new advancement in tissue imaging that is quickly gaining wider usage since its recent launch. It improves upon current tissue imaging methods by allowing...
9.
Ushida T, Cotechini T, Protopapas N, Atallah A, Collyer C, Toews A, et al.
J Dev Orig Health Dis
. 2022 Jun;
13(6):816.
PMID: 35758887
No abstract available.
10.
Ushida T, Cotechini T, Protopapas N, Atallah A, Collyer C, Toews A, et al.
J Dev Orig Health Dis
. 2022 May;
13(6):706-718.
PMID: 35593438
Children of women with pre-eclampsia have increased risk of cardiovascular (CV) and metabolic disease in adult life. Furthermore, the risk of pregnancy complications is higher in daughters born to women...